BlossomHill 制药

最新新闻

• Analysts Offer Insights on NA Companies: Expedia (EXPE) and BlossomHill Therapeutics, Inc. (BLSM)
  TipRanks · 2026/9/24
• Analysts Conflicted on These NA Names: Guardian Metal Resources PLC Sponsored ADR (GMTL), BlossomHill Therapeutics, Inc. (BLSM) and International Paper Co (IP)
  TipRanks · 2026/9/24
• 评级变动
  J.P. Morgan Maintains BlossomHill Therapeutics(BLSM.US) With Buy Rating
  \u5e02\u573a\u8d44\u8baf · 2026/9/18
• 评级变动
  A Quick Look at Today's Ratings for BlossomHill Therapeutics(BLSM.US), With a Forecast Between $28 to $35
  \u5e02\u573a\u8d44\u8baf · 2026/9/2
• 评级变动
  Analysts Are Bullish on These NA Stocks: BlossomHill Therapeutics, Inc. (BLSM), Micron (MU)
  TipRanks · 2026/9/21
• J.P. Morgan Maintains BlossomHill Therapeutics(BLSM.US) With Buy Rating, Announces Target Price $30
  \u5e02\u573a\u8d44\u8baf · 2026/9/24
• Leerink Partners Initiates BlossomHill Therapeutics(BLSM.US) With Buy Rating, Announces Target Price $40
  \u5e02\u573a\u8d44\u8baf · 2026/9/22
• H.C. Wainwright Maintains BlossomHill Therapeutics(BLSM.US) With Buy Rating, Maintains Target Price $35
  \u5e02\u573a\u8d44\u8baf · 2026/9/30
• 评级变动
  Analysts Offer Insights on NA Companies: BlossomHill Therapeutics, Inc. (BLSM), Amrize Ltd (AMRZ) and ServiceTitan, Inc. Class A (TTAN)
  TipRanks · 2026/9/18
• 评级变动
  LifeSci Capital Maintains BlossomHill Therapeutics(BLSM.US) With Buy Rating, Maintains Target Price $32
  \u5e02\u573a\u8d44\u8baf · 2026/9/16

新闻标题为自动聚合内容，未经我们团队独立核实或编辑。